Flash Sell! Moonshot Alzheimer’s Therapy No Better Than a Sugar Pill
If you shorted every biotech that’s tried to develop a new Alzheimer’s therapy over the course of the 21st century, you might be pretty rich by now. The track record is that bad. Hundreds of ideas have been tried, and hundreds have failed… And our Alzheimer’s play has been added to the list. Time to unload shares and move on…
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Ray Blanco’s FDA Profit Alert
The FDA Profit Alert focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.